Provided by Tiger Trade Technology Pte. Ltd.

Mirum Pharmaceuticals, Inc.

96.72
+0.41000.43%
Post-market: 96.720.00000.00%16:18 EDT
Volume:367.57K
Turnover:35.62M
Market Cap:6.28B
PE:-6.87
High:97.85
Open:96.31
Low:95.49
Close:96.31
52wk High:130.00
52wk Low:63.23
Shares:64.93M
Float Shares:56.42M
Volume Ratio:0.72
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.0800
EPS(LYR):-0.4700
ROE:-702.97%
ROA:-6.79%
PB:-602.59
PE(LYR):-205.79

Loading ...

U.S. RESEARCH ROUNDUP-CAVA Group, Eagle Materials, Vertiv

Reuters
·
May 20

Mirum Pharmaceuticals Initiated at Outperform by Wolfe Research

Dow Jones
·
May 19

Mirum Pharmaceuticals initiated with an Outperform at Wolfe Research

TIPRANKS
·
May 19

Mirum director Saira Ramasastry disposes of common shares worth $218,940

Reuters
·
May 19

Mirum plans USD 600 million convertible senior notes offering due 2032

Reuters
·
May 19

What Mirum Pharmaceuticals (MIRM)'s Volixibat PSC Trial Win and $600M Notes Deal Means For Shareholders

Simply Wall St.
·
May 18

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
May 15

Stock Track | Mirum Pharmaceuticals Soars 5.26% Intraday on Favorable Debt Offering and Positive Drug Trial Results

Stock Track
·
May 13

BRIEF-Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering

Reuters
·
May 13

Mirum Pharmaceuticals Prices $600.0 Million Convertible Senior Notes Offering; Refinances a Portion of 2029 Convertible Notes

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals announces $600M convertible senior notes offering

TIPRANKS
·
May 13

Mirum Pharmaceuticals Plans Offering of Senior Notes due 2032

MT Newswires Live
·
May 13

BUZZ-Mirum Pharma drops on announcing $600 mln convertible debt deal

Reuters
·
May 13

Mirum plans USD 600 million convertible senior notes offering due 2032

Reuters
·
May 13

Mirum Pharmaceuticals Inc - Initial Purchasers May Buy up to $90 Mln Additional Notes

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals Announces Proposed Convertible Senior Notes Offering

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals Inc - Notes to Mature on June 1, 2032

THOMSON REUTERS
·
May 13

Mirum Pharmaceuticals to present at H.C. Wainwright BioConnect investor conference

Reuters
·
May 12

RBC Capital Sticks to Its Buy Rating for Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
May 07

Mirum Pharmaceuticals Is Maintained at Outperform by Baird

Dow Jones
·
May 07